NasdaqCM - Nasdaq Real Time Price USD
AdaptHealth Corp. (AHCO)
8.41
+0.38
+(4.73%)
At close: April 25 at 4:00:00 PM EDT
8.53
+0.12
+(1.43%)
After hours: April 25 at 4:55:31 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
3,260,975
3,260,975
3,200,177
2,970,595
2,454,535
Cost of Revenue
2,579,882
2,579,882
2,576,110
2,390,480
2,008,925
Gross Profit
681,093
681,093
624,067
580,115
445,610
Operating Expense
404,283
404,283
391,681
389,704
220,005
Operating Income
276,810
276,810
232,386
190,411
225,605
Net Non Operating Interest Income Expense
-126,668
-126,668
-130,299
-109,414
-95,195
Other Income Expense
-14,123
-14,123
-825,871
16,905
60,549
Pretax Income
136,019
136,019
-723,784
97,902
190,959
Tax Provision
41,239
41,239
-49,004
24,769
32,806
Net Income Common Stockholders
82,747
82,747
-678,895
63,449
141,796
Average Dilution Earnings
--
--
-34,482
-17,158
-53,181
Diluted NI Available to Com Stockholders
82,747
82,747
-713,377
46,291
88,615
Basic EPS
-1.63
0.62
-5.06
0.47
1.12
Diluted EPS
-1.67
0.61
-5.31
0.33
0.67
Basic Average Shares
133,355
133,756
134,156
134,175
126,306
Diluted Average Shares
134,597.25
135,531
134,418
138,988
133,034
Total Operating Income as Reported
263,732
263,732
-598,401
190,411
225,605
Rent Expense Supplemental
71,874
71,874
68,375
65,979
48,586
Total Expenses
2,984,165
2,984,165
2,967,791
2,780,184
2,228,930
Net Income from Continuing & Discontinued Operation
90,422
90,422
-678,895
69,316
156,175
Normalized Income
98,319.01
98,319.01
63,261.26
56,498.97
104,523.53
Interest Expense
126,668
126,668
130,299
109,414
95,195
Net Interest Income
-126,668
-126,668
-130,299
-109,414
-95,195
EBIT
262,687
262,687
-593,485
207,316
286,154
EBITDA
628,021
628,021
-210,702
558,494
544,207
Reconciled Cost of Revenue
2,259,593
2,259,593
2,250,414
2,104,192
1,813,967
Reconciled Depreciation
365,334
365,334
382,783
351,178
258,053
Net Income from Continuing Operation Net Minority Interest
90,422
90,422
-678,895
69,316
156,175
Total Unusual Items Excluding Goodwill
-11,330
-11,330
-796,305
17,158
62,381
Total Unusual Items
-11,330
-11,330
-796,305
17,158
62,381
Normalized EBITDA
639,351
639,351
585,603
541,336
481,826
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-3,432.99
-3,432.99
-54,148.74
4,340.97
10,729.53
12/31/2021 - 5/31/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
QIPT Quipt Home Medical Corp.
2.1000
-1.87%
INGN Inogen, Inc.
7.28
+1.82%
OFIX Orthofix Medical Inc.
14.19
+1.72%
OSSFF Embla Medical hf.
4.1500
0.00%
HAE Haemonetics Corporation
62.51
+0.95%
EE5.F EL.En. S.p.A.
8.29
+2.47%
UFPT UFP Technologies, Inc.
206.80
-0.04%
SONX Sonendo, Inc.
1.1500
-14.81%
IART Integra LifeSciences Holdings Corporation
16.81
+0.66%
SIBN SI-BONE, Inc.
14.41
+0.14%